Equities

Unichem Laboratories Ltd

UNICHEMLAB:NSI

Unichem Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)895.30
  • Today's Change16.30 / 1.85%
  • Shares traded113.52k
  • 1 Year change+118.37%
  • Beta0.1871
Data delayed at least 15 minutes, as of Nov 14 2024 05:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1,5441,8543,761
Total Receivables, Net8,0517,4876,460
Total Inventory7,1276,2886,002
Prepaid expenses207234210
Other current assets, total132216
Total current assets16,94215,88516,449
Property, plant & equipment, net13,17114,02614,823
Goodwill, net151515
Intangibles, net000
Long term investments0.201.6133
Note receivable - long term1,1251,5541,564
Other long term assets5963--
Total assets31,69331,93033,188
LIABILITIES
Accounts payable2,9942,9071,832
Accrued expenses226340183
Notes payable/short-term debt1,5532,0812,157
Current portion long-term debt/capital leases299308299
Other current liabilities, total2,0087601,051
Total current liabilities7,0796,3965,521
Total long term debt6247511,036
Total debt2,4753,1403,492
Deferred income tax----0
Minority interest------
Other liabilities, total367430447
Total liabilities8,0697,5777,004
SHAREHOLDERS EQUITY
Common stock141141141
Additional paid-in capital131313
Retained earnings (accumulated deficit)23,54624,22025,292
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(76)(21)738
Total equity23,62424,35326,184
Total liabilities & shareholders' equity31,69331,93033,188
Total common shares outstanding707070
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.